Velcade Side Effects
View Community-reported Velcade side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Velcade Side Effect
Have You dealt with a Velcade side effect? Share your experience
Velcade Side Effects summary
Total Velcade reports: 2239.Velcade FDA safety alerts: No.
Reported deaths: 746 Reported hospitalizations: 1286.
Take Velcade Side Effects Survey, Discuss Velcade with others
Velcade Side Effects: diarrhoea, thrombocytopenia, pyrexia, disease progression, asthenia, neuropathy peripheral, platelet count decreased, hypotension, blood lactate dehydrogenase increased, atrial fibrillation, nausea,
Velcade Usage.
If you have questions about Velcade, you can ask a Health Expert or Ask Patient Community about Velcade.
Self-reported VELCADE Side Effects
Velcade Side Effects Report #SELF464 -2008-06-01
VELCADE problem was reported on 2008-06-01
Patient reported the following VELCADE side effects:"\""ACUTE, CRONIC, SEVERE\"" NEUROPATHY (words of neurologist)Had transplant Aug. 08 and it has NOT improved- numb feet & lower legs/fingers - sometimes extreme pain (today\'s date Nov. 7,08"Read more
Velcade Side Effects reported to FDA
Showing 1-40 of 2239 Next >
Velcade Side Effects Report #5671592-XPhysician from JAPAN reported VELCADE problem on Mar 03, 2008. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: computerised tomogram abnormal, oesophagitis. VELCADE dosage: unknown. Patient recovered.
Velcade Side Effects Report #5671737-1
VELCADE problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Female patient, 67 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atelectasis, back pain, condition aggravated, influenza, oedema peripheral, pneumonia. VELCADE dosage: 1.30 MG/M2,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, NEXIUM, TOPROL, BENICAR, ACTONEL, ALLEGREA, ALLEGRA. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5671739-5
Physician from UNITED STATES reported VELCADE problem on Mar 05, 2008. Male patient, 67 years of age, was diagnosed with myelodysplastic syndrome and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cellulitis. VELCADE dosage: 1.3 MG,INTRAVENOUS. During the same period patient was treated with REVLIMID, EXJADE, WELLBUTRIN, KLONOPIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5671741-3
VELCADE problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, weighting 190.5 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: constipation, ileus. VELCADE dosage: 1.30 MG/M2,IV BOLUS. During the same period patient was treated with REVLIMID. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5671743-7
Physician from UNITED STATES reported VELCADE problem on Mar 06, 2008. Male patient, 43 years of age, weighting 200.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure decreased, loss of consciousness, syncope, tremor. VELCADE dosage: 2.00 MG,INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5671837-6
VELCADE problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 11, 2008. Female patient, 61 years of age, weighting 115.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LEVODROPROPIZINE, THEOLAN, ACETYLCYSTEINE, BROMHEXINE HYDROCHLORIDE, SALBUTAMOL SULPHATE, FENOTEROL HYDROBROMIDE, ALPRAZOLAM, CEFTRIAXONE. Patient died on 07/13/2007.
Velcade Side Effects Report #5671838-8
Physician from FRANCE reported VELCADE problem on Mar 11, 2008. Male patient, 57 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, CLODRONIC ACID, LYSINE ACETYLSALICYLATE, LOPERAMIDE. Patient was hospitalized. Patient died on 03/02/2008.
Velcade Side Effects Report #5672063-7
VELCADE problem was reported by a Health Professional from FRANCE on Feb 29, 2008. Female patient, child 1 years of age, was diagnosed with multiple myeloma, lung disorder and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, hyperthermia, platelet count decreased, purpura, pyrexia, rash erythematous, rash morbilliform. VELCADE dosage: unknown. During the same period patient was treated with REVLIMID, AUGMENTIN, OFLOXACIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5672070-4
Physician from FRANCE reported VELCADE problem on Mar 03, 2008. Male patient, 64 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: nausea, spinal cord compression, vomiting, weight decreased. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5674060-4
VELCADE problem was reported by a Health Professional from COLOMBIA on Mar 04, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetes mellitus. VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 02/27/2008.
Velcade Side Effects Report #5677061-5
Physician from JAPAN reported VELCADE problem on Mar 05, 2008. Female patient, 58 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bedridden, bone marrow failure, bronchopulmonary aspergillosis, condition aggravated, fungal infection, hepatic steatosis, herpes zoster, hypoaesthesia, liver disorder. VELCADE dosage: 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MUCOSTA, ALOSENN, VIT K CAP, RABEPRAZOLE, LOXONIN, HALCION, LASIX. Patient died on 04/10/2007.
Velcade Side Effects Report #5677073-1
VELCADE problem was reported by a Physician from GERMANY on Mar 05, 2008. Female patient, 62 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pain in extremity, polyneuropathy, restless legs syndrome, syncope. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with BISOPROLOL FUMARATE, TILIDIN, BISPHOSPHONATES, ALIZAPRIDE, POTASSIUM, NALOXONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677801-5
Physician from KOREA, REPUBLIC OF reported VELCADE problem on Mar 05, 2008. Male patient, 62 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chest pain, echocardiogram abnormal, economic problem, electrocardiogram abnormal, ischaemic cardiomyopathy. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, CHLORIDE, AMINO ACIDS, DEXTROSE INFUSION FLUID, PAMIDRONATE, GABAPENTIN, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677802-7
VELCADE problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 05, 2008. Male patient, 57 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dialysis, hyperkalaemia. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5677804-0
Physician from JAPAN reported VELCADE problem on Mar 04, 2008. Male patient, 57 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood urea increased, bone marrow failure, condition aggravated, diarrhoea, disease complication, faeces discoloured, gastritis erosive, gastritis haemorrhagic, haemoglobin decreased. VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS; 2.00 MG. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, PETROLATUM OINTEMENT, VIDARABINE, ALPROSTADIL, ZOMETA. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677805-2
VELCADE problem was reported by a Physician from JAPAN on Mar 04, 2008. Male patient, 54 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: back pain, blood chloride decreased, blood glucose increased, disease recurrence, graft versus host disease, haemorrhagic diathesis, hepatic function abnormal, herpes zoster, interstitial lung disease. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, DEXAMETHASONE, RABEPRAZOLE, ITRACONAZOLE, PROGRAF, LEVOFLOXACIN, BAKTAR, ADONA. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677807-6
Physician from JAPAN reported VELCADE problem on Mar 06, 2008. Female patient, 70 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, thrombocytopenia. VELCADE dosage: 1.60 MG, INTRAVENOUS; 1.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5677810-6
VELCADE problem was reported by a Physician from GERMANY on Mar 03, 2008. Female patient, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. VELCADE dosage: 2.70 MG, INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5677942-2
Health Professional from UNITED STATES reported VELCADE problem on Mar 06, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, fatigue, hypoglycaemia, liver function test abnormal, nausea, neutropenia. VELCADE dosage: 3.08 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677943-4
VELCADE problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 56 years of age, weighting 200.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, pulmonary toxicity. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5677944-6
Pharmacist from UNITED STATES reported VELCADE problem on Mar 11, 2008. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, disease complication. VELCADE dosage: 1.00 MG/M2. Patient was hospitalized. Patient died.
Velcade Side Effects Report #5678125-2
VELCADE problem was reported by a Physician from JAPAN on Mar 07, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, bedridden, catheter related complication, deep vein thrombosis, disease progression, neuropathy peripheral, oedema peripheral, pulmonary embolism, tumour lysis syndrome. VELCADE dosage: 1.90 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE. Patient died on 10/29/2007.
Velcade Side Effects Report #5678126-4
Physician from JAPAN reported VELCADE problem on Mar 10, 2008. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic function abnormal, hepatic neoplasm, leukaemia, multiple myeloma, petechiae, platelet count decreased, pleural effusion, pneumonia. VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, ASPIRIN, METHYCOBAL, MAGNESIUM OXIDE, RED BLOOD CELLS, PLATELETS. Patient was hospitalized. Patient died on 10/03/2007.
Velcade Side Effects Report #5678128-8
VELCADE problem was reported by a Physician from GERMANY on Mar 07, 2008. Female patient, weighting 183.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia, suicide attempt. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, TORSEMIDE, POTASSIUM CHLORIDE, ZOLEDRONIC ACID, MESNA, METAMIZOL NATRIUM, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678129-X
Health Professional from SWEDEN reported VELCADE problem on Mar 10, 2008. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dyspnoea. VELCADE dosage: 2.70 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, COCILLANA, PREDNISOLONE, KODEIN RECIP, EUSAPRIMTE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678130-6
VELCADE problem was reported by a Physician from RUSSIAN FEDERATION on Mar 14, 2008. Female patient, 56 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, renal failure chronic, thrombocytopenia. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with ETHAMSYLATE, SORBIFER DURULES, FOLIC ACID. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678132-X
Consumer or non-health professional from RUSSIAN FEDERATION reported VELCADE problem on Mar 06, 2008. Female patient, child 1 years of age, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression, tonsillitis, upper respiratory tract infection. VELCADE dosage: unknown. Patient recovered.
Velcade Side Effects Report #5678134-3
VELCADE problem was reported by a Physician from CANADA on Mar 07, 2008. Female patient, 85 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: left ventricular dysfunction. VELCADE dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PAMIDRONATE DI, BENARYL, CIPROFLOXACIN, CEFTRIAXONE, VANCOMYCIN, IMOVANE, RANITIDINE. Patient recovered.
Velcade Side Effects Report #5678136-7
Physician from KOREA, REPUBLIC OF reported VELCADE problem on Mar 10, 2008. Male patient, 79 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: septic shock. VELCADE dosage: 1.3 MG/M2, INTRAVENOUS. Patient died on 06/07/2007.
Velcade Side Effects Report #5678139-2
VELCADE problem was reported by a Physician from JAPAN on Mar 09, 2008. Female patient, 66 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: lung disorder. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5678140-9
Physician from KOREA, REPUBLIC OF reported VELCADE problem on Mar 10, 2008. Female patient, 55 years of age, weighting 144.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 11/20/2007.
Velcade Side Effects Report #5678780-7
VELCADE problem was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient, 86 years of age, weighting 164.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, arthritis bacterial, cellulitis, chondrocalcinosis pyrophosphate, deep vein thrombosis, erythema, faecal incontinence, gout, international normalised ratio increased. VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ACYCLOVIR, ASPIRIN, CARDURA, COLACE, LASIX. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678782-0
Physician from UNITED STATES reported VELCADE problem on Mar 12, 2008. Male patient, 61 years of age, was diagnosed with amyloidosis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, coronary artery bypass, ejection fraction decreased, swollen tongue, weight decreased. VELCADE dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5678784-4
VELCADE problem was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient, 86 years of age, weighting 164.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, chondrocalcinosis pyrophosphate, constipation, decreased appetite, dysstasia, fall, haemarthrosis. VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ZOFRAN, POTASSIUM CHLORIDE, VITAMIN E, PROTONIX, ULTRAM. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678789-3
Physician from UNITED STATES reported VELCADE problem on Mar 10, 2008. Female patient, 65 years of age, weighting 185.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, angina pectoris, bronchitis, feeling hot, myocardial ischaemia, neuropathy peripheral. VELCADE dosage: 1.00 MG/M2, IV BOLUS. During the same period patient was treated with AREDIA, HYDRALAZINE, TOPROL, STROVITE, NEURONTIN, FENTANYL, ASPIRIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5678790-X
VELCADE problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atelectasis, haematocrit decreased, haemoglobin decreased, influenza, lymphocyte count decreased, monocyte count decreased, oedema peripheral, platelet count decreased, pneumonia. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, NEXIUM, TOPROL, BENICAR, ACTONEL, ALLEGRA. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5679411-2
Physician from GERMANY reported VELCADE problem on Mar 12, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, gastric haemorrhage, gastric ulcer, nausea, oesophageal candidiasis, oxygen saturation decreased, somnolence, tachyarrhythmia. VELCADE dosage: 1.75 MG, INTRAVENOUS. During the same period patient was treated with METOPROLOL SUCCINATE, PREDNISOLONE, TOREM, PANTOPRAZOLE, PASPERTIN, NOVAMIN, MIRTAZAPINE, DIGIMERCK. Patient died on 11/22/2007.
Velcade Side Effects Report #5679416-1
VELCADE problem was reported by a Physician from MALAYSIA on Mar 12, 2008. Female patient, child 1 years of age, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, septic shock. VELCADE dosage: 2.10 MG. Patient died on 02/09/2008.
Velcade Side Effects Report #5679419-7
Physician from GERMANY reported VELCADE problem on Mar 11, 2008. Female patient, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. VELCADE dosage: 2.70 MG, INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5679420-3
VELCADE problem was reported by a Physician from MALAYSIA on Mar 12, 2008. Female patient, weighting 180.8 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, PAMIDRONATE DI. Patient died on 02/25/2008.
Showing 1-40 of 2239 Next >